Modus Therapeutics will present new research on sevuparin for chronic kidney disease (CKD) with anemia at the 32nd Symposium on Glycosaminoglycans, held 18–20 September at Villa Vigoni, Italy. The ...
Modus Therapeutics presented data on sevuparin demonstrating its potential to treat anemia in chronic kidney disease at the annual American Society of Hematology (ASH) STOCKHOLM, SWEDEN – 11 December ...
WASHINGTON & SANTA MONICA, Calif.--(BUSINESS WIRE)--Aparavi®, a catalyst in data intelligence and automation software, and Modus, a leading provider of eDiscovery and Information Governance services, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results